In February 2021, a woman in Louisiana ran out of hairspray and reached for a can of Gorilla Glue instead; the adhesive set. Home remedies failed. She went to her local emergency room and was sent away with acetone wipes that burned her scalp. Then she posted a video; the video went around the world, and millions of people spent a week making jokes about her.

I am the surgeon who took the glue out. It took four hours, a solvent my team formulated for the purpose, and roughly twelve thousand dollars’ worth of care that I did not charge her for. She kept her hair.

The woman the internet was laughing at was Black. The surgeon who fixed it was African. Neither fact stayed in the news very long, and both of them are the story. Because everything that finally helped that woman existed the entire month she was suffering. The chemistry existed. The specialist existed. The operating room existed. None of it reached her until she went viral. She did not lack medicine. She lacked access to it, and what closed the gap was not a health system. It was an algorithm.

Now run the counterfactual on me, because that is the uncomfortable half. Had I never left Kumasi, that case does not get solved. Had Ghana built what we are building now in Ada, I would never have had to leave for those hands to exist in the first place. Same surgeon, same solvent; only the operating room address changes. That is Africa’s brain drain in a single case, with my own name on it.

Tomorrow morning in Ada, in Ghana’s Greater Accra Region, we put shovels into the ground for Medical City, a hospital complex built on the premise that Africans should not have to leave Africa, or go viral, to be treated well. I want to explain why a surgeon ended up in the construction business, and why the people funding African health care have been looking for the money in the wrong place. Start with the ledger, because the numbers are not in dispute.

Africa produces roughly three percent of the world’s pharmaceutical output. We import between seventy and eighty percent of the medicines our people actually swallow. For active pharmaceutical ingredients, the molecules that make a medicine a medicine, dependency runs above ninety-five percent. For vaccines in the WHO African region, it is around ninety-nine percent. We carry about a quarter of the world’s disease burden and

manufacture almost none of the world’s cure.

Meanwhile, we export the people who could fix that. Over one recent decade, African-trained physicians left for the United States at a rate of roughly one a day, most from a handful of countries, Ghana among them. We do not sell this talent; we donate it.

One analysis put the training investment lost by just nine sub-Saharan countries at around two billion dollars. And because our citizens do not trust what they can get at home, they leave too: an estimated seven billion dollars a year flows out of the continent as medical tourism, with more than three hundred thousand Africans traveling to India alone each year.

Read those columns together, and the machine is obvious. We export the mind that would have made the medicine. We import the medicine at a markup. Then we export the patient to go find the doctor we exported in the first place. We pay three times for the same failure.

This is not poverty. Poverty is when there is nothing. This is leakage, when there is plenty, and it is running out through a hole in the floor.

I learned the cost of that hole before I learned the economics of it. A year after I left Ghana for America, my mother died. She was forty. Her liver failed, and as it failed, the ammonia her body could no longer clear rose into her brain and changed her. She said things that made no sense. She stopped recognizing people she had known all her life. And so the word went around that she had lost her mind, that something had taken

hold of her.
She had not lost her mind. She was being poisoned by her own blood. It is a condition with a name and a protocol, managed every day in hospitals all over the world. Nobody around her was cruel or foolish. They were doing what people do when there is no system: they reached for the only explanation available. When a community cannot get a diagnosis, it will use a story instead. That is what a health system is, in the end. It is the

difference between a diagnosis and a story.
So who pays to build one? The reflex answer is donors, or governments, or development banks. I think the reflex is wrong, and the evidence is sitting in plain sight. Last year, Ghanaians abroad sent home nearly $7.8 billion, about six percent of the country’s GDP, and now more than foreign direct investment. Across the continent, the diaspora sends home something in the region of $100 billion a year, more than all

foreign aid combined.
The African Union counts us, its sixth region, at more than 170 million people. Africa does not lack capital. Africa lacks vehicles. I say this as a repeat offender. For twenty-five years I have wired money home, and almost all of it was consumed: school fees, a hospital bill, a funeral, a roof. Necessary, every cedi of it, and gone. It has to be sent again next month, and the month after, for forty years. That is not investment. It is a subscription to someone else’s emergency. One hundred billion dollars a year crosses an ocean and buys us no shares in anything. We may be the only investors on earth who transfer money every month and never ask for equity.

Consider one percent. One percent of Ghana’s annual remittances is $78 million. One percent of Africa’s is a billion dollars a year, permanent, renewable, requiring no new donor and nobody’s permission, deployed into African health infrastructure and owned by Africans.

For that to be more than a slogan, three things have to exist. Instruments: regulated, audited, boring vehicles that a nurse in Maryland can buy into for a few hundred dollars and actually track, rather than a WhatsApp message from a cousin with a project.

Procurement: African clinics, hospitals, and ministries deliberately buying African-made products, because a market served from Mumbai and Shenzhen builds someone else’s industry with our demand. And policy that holds still: harmonized regulation, so a medicine approved in Accra is not relitigated in Nairobi, and predictable offtake, so a manufacturer who builds a line knows the line will be bought. In February, African leaders committed to meeting sixty percent of the continent’s health-product needs locally by 2040. That target is a sentence in a document until those three things turn it into a factory.

The woman in Louisiana got her four hours because millions of strangers happened to be watching. A child in Kumasi holding a counterfeit antimalarial will never trend. Access that depends on being noticed is not access; it is luck with better public relations. Systems are what make good care ordinary. Which is the entire argument for building one.

I think about all of this the way I think about a hand. Early in my training, I spent twenty hours at a microscope replanting four fingers on a

bus driver. The order is not negotiable. Bone first, because nothing holds without a frame. Then the artery; until the blood flows, nothing you do afterward matters. Then veins, then tendons. Nerves last, because they take the longest; they regenerate about a millimeter a day, and you cannot hurry them.

Africa’s medical talent is not dead. It is severed, alive, superbly trained, and working in Houston and Manchester and Riyadh, separated from the body that grew it. Ada is the bone. Capital is the artery. And trust is the nerve: the mother who believes the medicine in her hand is real, the patient who does not book the flight to Delhi. That will take years to come back. It always does. But I have stood in that operating room and watched gray turn pink. It is worth the twenty hours.

THE WRITER
Michael K. Obeng, MD, FACS, PhD (Hon)
Diplomate, American Board of Plastic Surgery